LEXARIA BIOSCIENCE CORP. Repayments of Related Party Debt
LEXARIA BIOSCIENCE CORP. (LEXX) reported Repayments of Related Party Debt of $0 for the 9-month period ending 2018-05-31, per its 10-Q filed 2018-07-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2018-07-13
- LEXARIA BIOSCIENCE CORP. repayments of related party debt for the quarter ending 2018-05-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. repayments of related party debt for the quarter ending 2018-02-28 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. repayments of related party debt for the quarter ending 2017-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. repayments of related party debt for the quarter ending 2017-05-31 was $32.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month |
|---|---|---|---|
| 2018-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $0.00 derived: sum of 2 quarters · filed 2018-07-13 | $0.00 10-Q · filed 2018-07-13 |
| 2018-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $0.00 10-Q · filed 2018-04-12 | |
| 2017-11-30 | $0.00 10-Q · filed 2018-01-12 | ||
| 2017-05-31 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $45.50K derived: sum of 2 quarters · filed 2018-07-13 | $50.00K 10-Q · filed 2018-07-13 |
| 2017-02-28 | $13.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $18.00K 10-Q · filed 2018-04-12 | |
| 2016-11-30 | $4.50K 10-Q · filed 2018-01-12 | ||
| 2016-05-31 | $0.00 10-Q · filed 2017-07-14 | ||
| 2016-02-29 | $0.00 10-Q · filed 2017-04-14 | ||
| 2015-11-30 | $0.00 10-Q · filed 2017-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |